Clinical Trials

DermatologicHead & NeckSarcoma

420 enrolled

Eyelid Squamous Cell Carcinoma

NCT07530887 2026-04-15

NORMA-2

1,749 enrolled

Melanoma

NCT02821013 2026-04-14

STOP-GAP

614 enrolled

Melanoma

NCT02506153 2026-04-13

Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery

1,301 enrolled 16 charts

Melanoma

NCT03271372 2026-04-13

ADAM

101 enrolled

Carcinoma, Merkel Cell

NCT06743126 2026-04-13

SUPRAME

360 enrolled

Melanoma, Cutaneous Malignant

NCT04099251 2026-04-09

CheckMate76K

790 enrolled 18 charts 2 FDA

Melanoma

NCT06585410 2026-04-08

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

369 enrolled

Skin Neoplasms

NCT04657991 2026-04-07

A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

257 enrolled

Melanoma, Skin Neoplasms

NCT05662202 2026-04-03

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

172 enrolled

Keratosis, Actinic

NCT05727904 2026-04-03

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

670 enrolled

Melanoma, Skin Neoplasms

NCT06470451 2026-04-03

FLASH2

80 enrolled

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

NCT06500455 2026-04-03

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

BreastCNSDermatologicGenitourinaryThoracic

269 enrolled

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT03969004 2026-03-27

Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma

415 enrolled 3 FDA

Cutaneous Squamous Cell Carcinoma

NCT05907122 2026-03-27

A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma

256 enrolled

Melanoma

NCT06135415 2026-03-25

TirbAKare

DermatologicOther neoplasm

280 enrolled

Keratosis, Neoplasms, Precancerous Conditions, Keratosis, Actinic

NCT02362594 2026-03-05

MK-3475-054

1,019 enrolled 16 charts 2 FDA

Melanoma

NCT07144345 2026-03-05

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp

DermatologicOther neoplasm

160 enrolled

Precancerous Conditions, Skin Diseases, Keratosis, Actinic

NCT06246149 2026-03-04

ATOM

290 enrolled

Uveal Melanoma

NCT06007690 2026-03-02

CoMpass

100 enrolled

Uveal Melanoma, Eye Neoplasms

NCT01909453 2026-02-27

COLUMBUS

921 enrolled 48 charts 2 FDA

Melanoma, Neoplasm Metastasis, Neoplasms, Skin Diseases, Skin Neoplasms

NCT06346067 2026-02-27

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

78 enrolled

Melanoma

NCT00003641 2026-02-25

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

1,150 enrolled 6 charts

Melanoma

NCT05549297 2026-02-25

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

540 enrolled

Melanoma, Nevus, Blue

NCT06587451 2026-02-24

Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®

Phase 3 Terminated

52 enrolled

Melanoma

NCT07144852 2026-02-20

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities

DermatologicOther neoplasm

260 enrolled

Precancerous Conditions, Skin Diseases, Keratosis, Actinic

NCT06246916 2026-02-19

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

560 enrolled

Melanoma

NCT01274338 2026-02-18

Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

1,673 enrolled 19 charts

Melanoma

NCT02224781 2026-02-18

Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

267 enrolled 8 charts

Melanoma

NCT07015190 2026-02-18

Neoadjuvant Darovasertib in Primary Uveal Melanoma

520 enrolled

Uveal Melanoma, Melanoma

NCT03820986 2026-02-09

LEAP-003

674 enrolled 21 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

NCT07381972 2026-02-02

Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma

142 enrolled

Nodular Basal Cell Carcinoma of Skin

NCT01983748 2026-01-28

Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma

200 enrolled

Phase 3 Not yet recruiting

Uveal Melanoma

NCT05212246 2026-01-22

B3C

1,630 enrolled

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Patient Compliance, Keratosis, Actinic

NCT07221734 2026-01-21

Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma

632 enrolled